Rubiayannone A

CAS No. 517918-25-1

Rubiayannone A( ——— )

Catalog No. M38310 CAS No. 517918-25-1

Rubiayannone A is an anthraquinone glycoside with an antiplatelet aggregation activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 1408 Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Rubiayannone A
  • Note
    Research use only, not for human use.
  • Brief Description
    Rubiayannone A is an anthraquinone glycoside with an antiplatelet aggregation activity.
  • Description
    Rubiayannone A is an anthraquinone glycoside with an antiplatelet aggregation activity.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    517918-25-1
  • Formula Weight
    550.469
  • Molecular Formula
    C25H26O14
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Meei-Jen Liou, et al. Constituents from Rubia Ustulata Diels and R. Yunnanensis Diels and Their Antiplatelet Aggregation Activity. Journal of the Chinese Chemical Society, 24 September 2013.
molnova catalog
related products
  • [pSer2, pSer5, pSer7...

    [pSer2, pSer5, pSer7]-CTD is a substrate for CDK7(cyclin-dependent protein kinase), a phosphorylated polypeptide at ser2, ser5, and ser7 of RNA polymerase II carboxyl terminus (CTD).

  • Reptoside

    Reptoside, which can be extracted from the roots and above-ground parts of Cortex Eucommiae and Ajuga chamaepitys (L.) Schreb, is one of the active cyclic enol ether terpene glycosides of Cortex Eucommiae for the treatment of osteoporosis.

  • TCS PrP Inhibitor 13

    TCS PrP Inhibitor 13 is an antiprion agent inhibiting protease-resistant prion protein (PrP-res) accumulation.